EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

TOX as a new diagnostic marker for T cell large granular lymphocytic leukaemia

Manske M L Burg, Lydia Visser, Arjan Diepstra iD

Histopathology · 2024

DOI: 10.1111/his.15114 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Histopathology, 2024. Verfasst von Manske M L Burg und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Medical Biology, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands. Hauptthemen laut MEDLINE: Leukemia, Large Granular Lymphocytic, Lymphocytosis. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: University Medical Centre Groningen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

T cell large granular lymphocytic leukaemia (T‐LGLL) is a rare disorder that may underlie otherwise unexplained cytopenias. The identification of T‐LGLL cells in bone marrow biopsies can be a challenge, because a robust immunohistochemistry marker is lacking. The markers currently in use (granzyme B, TIA‐1 and CD8) are difficult to interpret or lack specificity. Therefore, we investigated whether immunohistochemistry for thymocyte selection‐associated high‐mobility group box (TOX), a transcription factor that associates with chronic T cell stimulation, could be a reliable tool for the identification of T‐LGLL cells. Methods and results In this retrospective study, expression of TOX in CD8 + cells in bone marrow biopsies of T‐LGLL patients ( n = 38) was investigated and compared to bone marrow of controls with reactive T cell lymphocytosis ( n = 10). All biopsies were evaluated for TOX staining within the CD8‐positive T cell population. The controls were essentially negative for TOX, whereas all T‐LGLL cases were positive (median = 80%, range = 10–100%), even when bone marrow involvement was subtle.

Conclusion

TOX is a highly sensitive marker for the neoplastic cells of T‐LGLL and we recommend its use, especially in the diagnostic work‐up of patients with unexplained cytopenias.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Large Granular LymphocyticLymphocytosisHumansBone MarrowCD8-Positive T-LymphocytesRetrospective StudiesHigh Mobility Group Proteins

Stichwörter der Autor:innen

T cell large granular lymphocytic leukaemiaTOX proteinbone marrowcytopeniadiagnosisimmunohistochemistry

Substanzen

TOX protein, humanHigh Mobility Group Proteins

Autor:innen und Institutionen

  • Department of Pathology and Medical Biology, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands.

ORCID-Profile: Arjan Diepstra

Förderung

  • University Medical Centre Groningen

Zitieren

APA

Burg, M. M. L., Visser, L., & Diepstra, A. (2024). TOX as a new diagnostic marker for T cell large granular lymphocytic leukaemia. Histopathology. https://doi.org/10.1111/his.15114

Vancouver

Burg MML, Visser L, Diepstra A. TOX as a new diagnostic marker for T cell large granular lymphocytic leukaemia. Histopathology. 2024. doi:10.1111/his.15114

BibTeX
@article{Burg2024,
  author = {Burg, Manske M L and Visser, Lydia and Diepstra, Arjan},
  title = {TOX as a new diagnostic marker for T cell large granular lymphocytic leukaemia},
  journal = {Histopathology},
  year = {2024},
  doi = {10.1111/his.15114}
}
Kostenlos starten →